Skip to content

Alliance for Hippocratic Medicine v. Food and Drug Administration

Petition for certiorari denied on December 13, 2023

Docket No. Op. Below Argument Opinion Vote Author Term
23-395 5th Cir. N/A N/A N/A N/A OT 2023

Issue: (1) Whether the Alliance's challenge to the Food and Drug Administration"s 2000 mifepristone approval is timely; and (2) whether FDA"s 2000 approval of mifepristone under 21 C.F.R. 314.500, which applies only to drugs that "treat[ ] serious or life-threatening illnesses," and FDA"s subsequent approval of generic mifepristone were unlawful.

SCOTUSblog Coverage

DateProceedings and Orders (key to color coding)
10/12/2023Petition for a writ of certiorari filed. (Response due November 15, 2023)
11/07/2023Brief of respondent Danco Laboratories, LLC in opposition filed.
11/07/2023Brief of Federal Cross-Respondents in opposition filed.
11/13/2023Brief amici curiae of Mississippi, et al. filed.
11/15/2023Brief amicus curiae of Human Coalition filed.
11/15/2023Brief amici curiae of 109 Members of Congress filed.
11/15/2023Amicus brief of 109 Members of Congress not accepted for filing. (February 09, 2024 -- Duplicate submission)
11/21/2023DISTRIBUTED for Conference of 12/8/2023.
11/28/2023Reply of petitioners Alliance for Hippocratic Medicine, et al. filed. (Distributed)
12/13/2023Petition DENIED.